Veraxa Biotech Holding AG Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
AQR Capital Management entities have filed a Schedule 13G, reporting a passive beneficial ownership of 0.46% in Veraxa Biotech Holding AG.